Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

The Biden administration, in one of its last major policy directives, proposed on Tuesday that Medicare and Medicaid cover ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden proposes Medicaid, Medicare cover ...

Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like ...